SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-011478
Filing Date
2020-01-22
Accepted
2020-01-22 07:30:32
Documents
4
Period of Report
2020-01-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d869331d8k.htm 8-K 17922
2 EX-99.1 d869331dex991.htm EX-99.1 21209
3 GRAPHIC g869331g0122045744217.jpg GRAPHIC 3223
4 GRAPHIC g869331g0122045744420.jpg GRAPHIC 3165
  Complete submission text file 0001193125-20-011478.txt   49353
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 20537554
SIC: 2834 Pharmaceutical Preparations